OOIR: Observatory of International Research

Papers

(The H4-Index of Allergy is 54. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)

Article	Citations
Issue Information	378
Issue Information	326
Type 2 memory B cells: The repository of allergic memory?	310
Issue Information	191
Correspondence to “Basophil activation test as predictor of severity and threshold of allergic reactions to egg”	190
Airway epithelial cell cilia transcriptomic dysregulation is associated with the inflammatory phenotype in asthma	189
Ficolin‐A Protects Against Allergic Asthma via Suppressing ILC2‐Drived Type 2 Inflammation	188
Dupilumab in Children Under 6 Years With Moderate‐to‐Severe Atopic Dermatitis: A 16‐Week Real‐World Prospective Study on Efficacy, Safety, and Local‐Systemic Immune Responses	136
One‐strength dose escalation of house dust mite depot product for subcutaneous immunotherapy is safe and tolerable	129
Atopic Dermatitis ( AD ) Related Cord Blood DNA Methylation Patterns Are Linked to Maternal	119
Clinical applicability of the urticaria control test in patients with chronic urticaria: Further evidence from 622 adult and pediatric patients with different disease subtypes	119
Adherence to Mediterranean Diet During Pregnancy, Breastfeeding, and Development of Food Allergy in the Offspring: Results From the MEDALLION Cohort Study	119
Transplacental Antimicrobial Antibodies and Childhood Asthma: Maternal Nativity as an Upstream Factor	118
Impact of climate change on atopic dermatitis: A review by the International Eczema Council	118
Next generation health guidelines: The role of real‐life data in evidence‐based medicine	112
	110
25‐hydroxyvitamin D and risk of atopic diseases and infections in early childhood	108
In Memory of Dr. Izabela Kuprys‐Lipinska: A Pioneering Clinician, Scientist, and Beloved Friend	102
Prospective (e‐diary) vs retrospective (ARIA) measures of severity in allergic rhinoconjunctivitis: An observational compatibility study	101
In memoriam: Lawrence M. Lichtenstein (1934–2022)	101
Impact of COVID‐19 on care‐seeking patterns for hay fever in Japan: A retrospective claims database cohort study	97
Correspondence to “Allergic bronchopulmonary aspergillosis with atopic, nonatopic, and sans asthma—Factor analysis”	95
Preclinical Development of GR2002, a Novel Anti‐TSLP Bispecific Antibody With Potent TSLP Inhibitory Effects	92
Cryopreservation Between Sample Processing and Analysis in Streamlined Basophil Activation Test	92
TOP10 ‐ SCAR : A Global Pharmacovigilance Study on Medications Most Frequently Related to Severe Cutaneous Adverse Rea	91

Vaccine based on folded receptor binding domain‐PreS fusion protein with potential to induce sterilizing immunity to SARS‐CoV‐2 variants	89
The second COVID‐19 mRNA vaccine dose enhances the capacity of Spike‐specific memory B cells to bind Omicron BA.2	88
IgG Removal Enhances the Sensitivity of Amoxicillin‐Specific IgE Detection in ImmunoCAP	83
Algorithms in allergy: An algorithm for alpha‐Gal syndrome diagnosis and treatment, 2024 update	82
Long‐term safety and efficacy of garadacimab for preventing hereditary angioedema attacks: Phase 3 open‐label extension study	80
Longitudinal analyses of development of the immune system during the first five years of life in relation to lifestyle	77
The Presence and Pathogenic Roles of M(IL‐33 + IL‐2) Macrophages in Allergic Airway Inflammation	75
A Systematic Review and Meta‐Analysis on the Induction of Confirmed Eosinophilic Esophagitis as a Side Effect of Allergen Immunotherapy: An EAACI Tas	74
Shotgun metagenomic sequencing on skin microbiome indicates dysbiosis exists prior to the onset of atopic dermatitis	73
Immunoglobulin E response in health and disease beyond allergic disorders	70
Hot topics in allergen immunotherapy, 2023: Current status and future perspective	69
The Role of IgE in Crohn's Disease by Impairing the Capacity of Plasmacytoid Dendritic Cells to Generate FOXP3⁺ Tregs	67
Oral and Gut Microbial Hubs Associated With Reaction Threshold Interact With Circulating Immune Factors in Peanut Allergy	67
Pre‐existing inflammation reduces the response to contact allergens in Tmem79‐deficient mice	66
An algorithm for the diagnosis and management of IgE‐mediated food allergy, 2024 update	65
Type I and II Interferons Drive Abacavir Hypersensitivity via Treg Suppression and T‐Cell Enhancement in Immunocompetent HLA	60
Core Outcome Set for IgE‐mediated food allergy clinical trials and observational studies of interventions: International Delphi consensus study ‘COMFA’	58
In vivo and ex vivo inflammatory responses of the esophageal mucosa to food challenge in adults with eosinophilic esophagitis	58
Autoantibodies in COVID‐19 correlate with antiviral humoral responses and distinct immune signatures	58
The impact of exposure to tobacco smoke and e‐cigarettes on asthma‐related outcomes: Systematic review informing the EAACI guidelines on environmental science for allergic diseases and asthma	58
Angiomotin and angiostatin as asthma biomarkers: Implications for the regulation of airway remodeling and inflammation	58
Dupilumab improves health related quality of life: Results from the phase 3 SINUS studies	57
Efficacy and safety of intranasal medications for allergic rhinitis: Network meta‐analysis	57
Intranasal administration of a virus like particles‐based vaccine induces neutralizing antibodies against SARS‐CoV‐2 and variants of concern	56
MUC1 deficiency induces the nasal epithelial barrier dysfunction via RBFOX3 shortage augment ubiquitin–proteasomal degradation in allergic rhinitis pathogenesis	56
Issue Information ‐ TOC	55
Issue Information	55
Issue Information	55
Oral abstracts (OAS)	54